Functional articular cartilage repair: Here, near, or is the best approach not yet clear?

Nature Reviews Rheumatology

Volumn 9, Issue 5, 2013, Pages 277-290

  Mastbergen, Simon C ^a   Saris, Daniël B F ^a,b   Lafeber, Floris P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGG 523; AGGRECANASE; ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; CELECOXIB; CHONDROITIN SULFATE; CINDUNISTAT; COLLAGENASE 3; DISEASE MODIFYING OSTEOARTHRITIS DRUG; DOXYCYCLINE; FIBROBLAST GROWTH FACTOR 18; GLUCOSAMINE SULFATE; OSTEOGENIC PROTEIN 1; PG 116800; PG 530742; PLACEBO; RECOMBINANT FIBROBLAST GROWTH FACTOR 18; RISEDRONIC ACID; SALCATONIN; SD 6010; STRONTIUM RANELATE; UNCLASSIFIED DRUG;

ANKLE OSTEOARTHRITIS; ARTICULAR CARTILAGE; AUTOLOGOUS CHONDROCYTE IMPLANTATION; AVASCULAR NECROSIS; BACTERIAL ARTHRITIS; BONE NECROSIS; BONE TURNOVER; CARTILAGE DEGENERATION; CHONDROCYTE IMPLANTATION; CHONDROLYSIS; DEVICE INFECTION; HEMOPHILIC ARTHROPATHY; HIP OSTEOARTHRITIS; HUMAN; JOINT DEGENERATION; JOINT DESTRUCTION; JOINT DISLOCATION; JOINT DISTRACTION; JOINT FRACTURE; JOINT SPACE NARROWING; JOINT SPACE WIDTH; JOINT SURGERY; KNEE DISEASE; KNEE OSTEOARTHRITIS; LUNG EMBOLISM; MESENCHYMAL STEM CELL; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOARTHRITIS; OSTEOCHONDRAL DEFECT; OSTEOCHONDROSIS; OSTEOPHYTE; OSTEOPOROSIS; PELVIC PIN PAIN; PELVIC TRACT INFECTION; PIN TRACT INFECTION; POSTOPERATIVE INFECTION; POSTTRAUMATIC ARTHROPATHY; POSTTRAUMATIC OSTEOARTHRITIS; POSTTRAUMATIC OSTEOPOROSIS; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT DISLOCATION; PROXIMAL INTERPHALANGEAL JOINT FRACTURE; REVIEW; THUMB DISLOCATION; THUMB FRACTURE; TISSUE REPAIR;

ANIMALS; ANTIRHEUMATIC AGENTS; CARTILAGE, ARTICULAR; CELL- AND TISSUE-BASED THERAPY; HUMANS; JOINT DISEASES; ORTHOPEDIC PROCEDURES;

EID: 84877625787     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.29     Document Type: Review

References (128)

1. Report No. CPMP/EWP/784/97 (Committee for Proprietary Medicinal Products [CPMP], London, 19986p
2. FDA. Guidance for induistry: clinical development programs for drugs, devices and biological products intended for the treatment of OA. U.S. Food and Drug Administration [online], http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm071577.pdf (19996p
3. Mastbergen, S. C. & Lafeber, F. P. Animal models of osteoarthritis - why choose a larger model? US Musculoskeletal Review 4, 11-14 (20096p
4. Bingham, C. O. 3rd.et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. 54, 3494-3507 (20066p
5. Bruyere O.et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: Results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 16, 254-260 (20086p
6. Dougados, M.et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum. 44, 2539-2547 (20016p
7. Manno, R. L.et al. OARSI-OMERACT initiative: Defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials. Osteoarthritis 20, 93-101 (20126p
8. Wluka, A. E., Wolfe, R., Stuckey, S. & Cicuttini, F. M. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann. Rheum. Dis. 63, 264-268 (20046p
9. Cicuttini, F. M.,Jones, G., Forbes, A. & Wluka, A. E. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: A prospective study. Ann. Rheum. Dis. 63, 1124-1127 (20046p
10. Bauer, D. C.et al. Classification of osteoarthritis biomarkers: A proposed approach. Osteoarthritis Cartilage 14, 723-727 (20066p
11. Hunter, D. J. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat. Rev. Rheumatol. 7, 13-22 (20116p
12. Martel-Pelletier, J.,Wildi, L. M. & Pelletier, J. P. Future therapeutics for osteoarthritis. Bone 51, 297-311 (20126p
13. Hellio le Graverand M.P.et al. A 2-year randomized, double-blind, placebo controlled, multicenter study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann. Rheum. Dis. 72, 187-195 (20126p
14. Pelletier, J. P.et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum. 43, 1290-1299 (20006p
15. Bijlsma, J. W., Berenbaum, F. & Lafeber, F. P. Osteoarthritis: An update with relevance for clinical practice. Lancet 377, 2115-2126 (20116p
16. Baragi, V. M.et al. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum. 60, 2008-2018 (20096p
17. Fosang, A. Knock-in mice reveal in vivo consequences of MMP activity for OA [abstract SP0022]. Ann. Rheum. Dis. 71 (Suppl. 3), 6 (20126p
18. Hunter D.J.et al. Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet. Disord. 11, 232 (20106p
19. Haque, T., Nakada, S. & Hamdy, R. C. A review of FGF18: Its expression, signaling pathways and possible functions during embryogenesis and post-natal development. Histol. Histopathol. 22, 97-105 (20076p
20. Ellman, M. B., An, H. S., Muddasani, P. & Im, H. J. Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 420, 82-89 (20086p
21. Moore, E. E.et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 13, 623-631 (20056p
22. McPherson, R., Flechsenhar, K., Hellot, S. & Eckstein, F. A randomized, double blind, placebo-controlled, multicenter study of rhFGF18 administered intraarticularly using single or multiple ascending doses in patients with primary knee osteoarthritis (OA), not expected to require knee surgery within 1 year. Osteoarthritis Cartilage 19 (Suppl. 1), 35-36 (20116p
23. Karsdal, M. A., Sondergaard, B. C., Arnold, M. & Christiansen, C. Calcitonin affects both bone and cartilage: A dual action treatment for osteoarthritis? Ann. N. Y. Acad. Sci. 1117, 181-195 (20076p
24. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT00704847 (20126p
25. Karsdal M.A.et al. Oral calcitonin demonstrated symptom-modifying efficacy and increased cartilage volume: Results from a 2-year phase 3 trial in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 19 (Suppl. 1), 35 (20116p
26. Marie, P. J., Ammann, P., Boivin, G. & Rey, C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif. Tissue Int. 69, 121-129 (20016p
27. Henrotin, Y.et al. Strontium ranelate increases cartilage matrix formation. J. Bone Miner. Res. 16, 299-308 (20016p
28. Alexandersen, P., Karsdal, M. A., Byrjalsen, I. & Christiansen, C. Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis. Climacteric 14, 236-243 (20116p
29. Cooper, C.et al. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: Rationale and design of randomised, double-blind, placebo-controlled trial. Curr. Med. Res. Opin. 28, 231-239 (20126p
30. Reginster, J. Y.et al. Efficacy and saftey of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial. Ann. Rheum. Dis. 72, 179-186 (20136p
31. Pelletier, J. P.et al. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1beta in the synovium. Ann. Rheum. Dis. 72, 250-257 (20136p
32. Li, Y.et al. Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells. Biochem. Biophys. Res. Commun. 418, 725-730 (20126p
33. Lafeber F. P. & van Laar J. M. Strontium ranelate: Ready for clinical use as disease-modifying osteoarthritis drug? Ann. Rheum. Dis. 72, 157-161 (20136p
34. Guermazi, A., Roemer, F. W. & Hayashi, D. Imaging of osteoarthritis: Update from a radiological perspective. Curr. Opin. Rheumatol. 23, 484-491 (20116p
35. van Spil, W. E., DeGroot, J., Lems, W. F., Oostveen, J. C. & Lafeber, F. P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: A systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 18, 605-612 (20106p
36. Buckwalter, J. A. & Mankin, H. J. Articular cartilage: Degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr. Course Lect. 47, 487-504 (19986p
37. Harris, J. D., Siston, R. A., Pan, X. & Flanigan, D. C. Autologous chondrocyte implantation: A systematic review. J. Bone Joint Surg. Am. 92, 2220-2233 (20106p
38. Lindahl, A., Brittberg, M. & Peterson, L. Health economics benefits following autologous chondrocyte transplantation for patients with focal chondral lesions of the knee. Knee Surg. Sports Traumatol. Arthrosc. 9, 358-363 (20016p
39. Brittberg, M. .. More bricks to the building of cartilage knowledge? Knee Surg. Sports Traumatol. Arthrosc. 17, 1275-1277 (20096p
40. Brittberg, M.et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331, 889-895 (19946p
41. Bentley, G.et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J. Bone Joint Surg. Br. 85, 223-230 (20036p
42. Jakobsen, R. B., Engebretsen, L. & Slauterbeck, J. R. An analysis of the quality of cartilage repair studies. J. Bone Joint Surg. Am. 87, 2232-2239 (20056p
43. Lohmander, L. S. Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease. J. Anat. 184 (Pt 3), 477-492 (19946p
44. Saris, D. B., Dhert, W. J. & Verbout, A. J. Joint homeostasis. The discrepancy between old and fresh defects in cartilage repair. J. Bone Joint Surg. Br. 85, 1067-1076 (20036p
45. Marijnissen, A. C. & Lafeber, F. P. Re: E. B. Hunziker. Articular cartilage repair: Basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage 2002; 10, 432-463 Osteoarthritis Cartilage 11, 300-301; author reply 302-304 (20036p
46. Zeifang, F.et al. Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: A randomized clinical trial. Am. J. Sports Med. 38, 924-933 (20106p
47. de Windt, T. S., Concaro, S., Lindahl, A., Saris, D. B. & Brittberg, M. Strategies for patient profiling in articular cartilage repair of the knee: A prospective cohort of patients treated by one experienced cartilage surgeon. Knee Surg. Sports Traumatol. Arthrosc. 20, 2225-2232 (20126p
48. Filardo, G., Kon, E., Di Martino, A., Iacono, F. & Marcacci, M. Arthroscopic second-generation autologous chondrocyte implantation: A prospective 7-year follow-up study. Am. J. Sports Med. 39, 2153-2160 (20116p
49. Kon, E.et al. Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years. Am. J. Sports Med. 37, 33-41 (20096p
50. Saris, D. B.et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am. J. Sports Med. 36, 235-246 (20086p
51. Roos, E. M. & Lohmander, L. S. The Knee injury and Osteoarthritis Outcome Score (KOOS): From joint injury to osteoarthritis. Health Qual. Life Outcomes 1, 64 (20036p
52. Roos, E. M., Roos, H. P., Lohmander, L. S., Ekdahl, C. & Beynnon, B. D. Knee Injury and Osteoarthritis Outcome Score (KOOS)-development of a self-administered outcome measure. J. Orthop. Sports Phys. Ther. 28, 88-96 (19986p
53. Knutsen, G.et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J. Bone Joint Surg. Am. 89, 2105-2112 (20076p
54. Knutsen, G.et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J. Bone Joint Surg. Am. 86-A, 455-464 (20046p
55. Peterson, L.et al. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin. Orthop. Relat. Res. 212-234 (20006p
56. Saris, D. B.et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am. J. Sports Med. 37 (Suppl. 1), 10-19 (20096p
57. Vanlauwe, J.et al. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: Early treatment matters. Am. J. Sports Med. 39, 2566-2574 (20116p
58. Bekkers, J. E., Inklaar, M. & Saris, D. B. Treatment selection in articular cartilage lesions of the knee: A systematic review. Am. J. Sports Med. 37 (Suppl. 1), 148-55 (20096p
59. de Windt, T. S., Bekkers, J. E., Creemers, L. B., Dhert, W. J. & Saris, D. B. Patient profiling in cartilage regeneration: prognostic factors determining success of treatment for cartilage defects. Am. J. Sports Med. 37 (Suppl. 1), 58-62 (20096p
60. Hendriks, J., Riesle, J. van Blitterswijk, C. A. Co-culture in cartilage tissue engineering. J. Tissue Eng. Regen. Med. 1, 170-178 (20076p
61. Leijten, J. C.,Georgi, N., Wu, L., van Blitterswijk, C. A. & Karperien, M. Cell sources for articular cartilage repair strategies: Shifting from monocultures to cocultures. Tissue Eng. Part B Rev. 19, 31-49 (20136p
62. Mo, X. T.et al. Variations in the ratios of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of cartilaginous and osseous phenotype in alginate constructs. Bone 45, 42-51 (20096p
63. Wu, L.et al. Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. Tissue Eng. Part A 17, 1425-1436 (20116p
64. European Medicines Agency. EU Clinical Trials Register [online], https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract-number: 2012-001570-29 (20126p
65. Lee, C. H.et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study. Lancet 376, 440-448 (20106p
66. Sekiya, I.et al. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J. Orthop. Res. 30, 943-949 (20126p
67. Gudas, R.et al. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am. J. Sports Med. 4, 2499-2508 (20126p
68. Centeno, C. J.et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr. Stem Cell Res. Ther. 5, 81-93 (20106p
69. Davatchi, F., Abdollahi, B. S., Mohyeddin, M., Shahram, F. & Nikbin, B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int. J. Rheum. Dis. 14, 211-215 (20116p
70. Koh, Y. G. & Choi, Y. J. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 19, 902-907 (20126p
71. Lafeber, F. P., Intema, F., Van Roermund, P. M. & Marijnissen, A. C. Unloading joints to treat osteoarthritis, including joint distraction. Curr. Opin. Rheumatol. 18, 519-525 (20066p
72. Intema, F.et al. Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage 19, 668-675 (20116p
73. Kanbe, K., Hasegawa, A., Takagishi, K., Kaneko, H. & Nakajima, Y. Arthroscopic findings of the joint distraction for the patient with chondrolysis of the ankle. Diagn. Ther. Endosc. 4, 101-105 (1997
74. Lamm, B. M. & Gourdine-Shaw, M. MRI evaluation of ankle distraction: A preliminary report. Clin. Podiatr. Med. Surg. 26, 185-191 (20096p
75. Marijnissen, A. C.et al. Clinical benefit of joint distraction in the treatment of severe osteoarthritis of the ankle: proof of concept in an open prospective study and in a randomized controlled study. Arthritis Rheum. 46, 2893-2902 (20026p
76. Paley, D., Lamm, B. M., Purohit, R. M. & Specht, S. C. Distraction arthroplasty of the ankle-how far can you stretch the indications? Foot Ankle Clin. 13, 471-484, ix (20086p
77. Ploegmakers, J. J.et al. Prolonged clinical benefit from joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage 13, 582-588 (20056p
78. Sabharwal, S. & Schwechter, E. M. Five-year followup of ankle joint distraction for post-traumatic chondrolysis in an adolescent: A case report. Foot Ankle Int. 28, 942-948 (20076p
79. Saltzman, C. L., Hillis, S. L., Stolley, M. P., Anderson, D. D. & Amendola, A. Motion versus fixed distraction of the joint in the treatment of ankle osteoarthritis: A prospective randomized controlled trial. J. Bone Joint Surg. Am. 94, 961-970 (20126p
80. Tellisi, N., Fragomen, A. T., Kleinman, D., O'Malley, M. J. & Rozbruch, S. R. Joint preservation of the osteoarthritic ankle using distraction arthroplasty. Foot Ankle Int. 30, 318-325 (20096p
81. Van Meegeren, M. E.et al. Joint distraction results in clinical and structural improvement of haemophilic ankle arthropathy: A series of three cases. Haemophilia 18, 810-817 (20126p
82. van Valburg, A. A.et al. Can Ilizarov joint distraction delay the need for an arthrodesis of the ankle? A preliminary report. J. Bone Joint Surg. Br. 77, 720-725 (19956p
83. van Valburg, A. A.et al. Joint distraction in treatment of osteoarthritis: A two-year follow-up of the ankle. Osteoarthritis Cartilage. 7, 474-479 (19996p
84. Abouheif, M. M.et al. Repair of a large osteochondral defect in the knee joint using autologous and artificial bone graft combined with motion preserving distraction arthroplasty: A case report. Arch. Orthop. Trauma Surg. 130, 231-236 (20106p
85. Aldegheri, R., Trivella, G. & Saleh, M. Articulated distraction of the hip. Conservative surgery for arthritis in young patients. Clin. Orthop. Relat. Res. 94-101 (19946p
86. Aly, T. A., Hafez, K. & Amin, O. Arthrodiatasis for management of knee osteoarthritis. Orthopedics 34, e338-e343 (20116p
87. Deie, M.et al. Knee articulated distraction arthroplasty for the middle-aged osteoarthritic knee joint. Tech. Knee Surg. 9, 80-84 (20106p
88. Deie, M., Ochi, M., Adachi, N., Kajiwara, R. & Kanaya, A. A new articulated distraction arthroplasty device for treatment of the osteoarthritic knee joint: A preliminary report. Arthroscopy 23, 833-838 (20076p
89. Gomez, J. A.et al. Articulated hip distraction: A treatment option for femoral head avascular necrosis in adolescence. J. Pediatr. Orthop. 29, 163-169 (20096p
90. Intema, F.et al. Tissue structure modification in knee osteoarthritis by use of joint distraction: An open 1-year pilot study. Ann. Rheum. Dis. 70, 1441-1446 (20116p
91. Thacker, M. M., Feldman, D. S., Madan, S. S., Straight, J. J. & Scher, D. M. Hinged distraction of the adolescent arthritic hip. J. Pediatr. Orthop. 25, 178-182 (20056p
92. Koshino, T., Wada, S., Ara, Y. & Saito, T. Regeneration of degenerated articular cartilage after high tibial valgus osteotomy for medial compartmental osteoarthritis of the knee. Knee 10, 229-236 (20036p
93. Marijnissen, A. C.et al. Knee Images Digital Analysis (KIDA): A novel method to quantify individual radiographic features of knee osteoarthritis in detail. Osteoarthritis Cartilage 16, 234-243 (20086p
94. Wiegant, K.et al. Structural tissue changes and prolonged clinical improvement by joint distraction in treatment of end-stage knee osteoarthritis; the 2 years follow-up. Osteoarthritis Cartilage, 19 (Suppl. 1), 36 (20116p
95. Bain, G. I., Mehta, J. A., Heptinstall, R. J. & Bria, M. Dynamic external fixation for injuries of the proximal interphalangeal joint. J. Bone Joint Ssurg. Br. 80, 1014-1019 (19986p
96. DeVries, J. G., Amiot, R. A., Cummings, P. & Sockrider, N. Freiberg's infraction of the second metatarsal treated with autologous osteochondral transplantation and external fixation. J. Foot Ankle Surg. 47, 565-570 (20086p
97. van Roermund, P. M.et al. Function of stiff joints may be restored by Ilizarov joint distraction. Clin. Orthop. Relat. Res. 220-227 (19986p
98. Judet, R. & Judet, T. [The use of a hinge distraction apparatus after arthrolysis and arthroplasty (author's transl)]. Revue de chirurgie orthopedique et reparatrice de l'appareil moteur [French] 64, 353-365 (19786p
99. Cañadell, J., Gonzales, F., Barrios, R. H. & Amillo, S. Arthrodiastasis for stiff hips in young patients. Int. Orthop. 17, 254-258 (19936p
100. Morrey, B. F. Posttraumatic stiffness: Distraction arthroplasty. Orthopedics 15, 863-869 (19926p
101. Clifford, A., O'Connell, M., Gabriel, S., Miller, L. E. & Block, J. E. The KineSpring load absorber implant: Rationale, design and biomechanical characterization. J. Med. Eng. Technol. 35, 65-71 (20116p
102. Allen, M. J.et al. Evaluation of the safety of a novel knee load-bypassing device in a sheep model. J. Bone Joint Surg. Am. 94, 77-84 (20126p
103. Kajiwara, R.et al. Effective repair of a fresh osteochondral defect in the rabbit knee joint by articulated joint distraction following subchondral drilling. J. Orthop. Res. 23, 909-915 (20056p
104. Nishino, T.et al. Joint distraction and movement for repair of articular cartilage in a rabbit model with subsequent weight-bearing. J. Bone Joint Surg. Br. 92, 1033-1040 (20106p
105. Nishino, T.et al. Effect of gradual weight-bearing on regenerated articular cartilage after joint distraction and motion in a rabbit model. J. Orthop. Res. 28, 600-606 (20106p
106. Yanai, T., Ishii, T., Chang, F. & Ochiai, N. Repair of large full-thickness articular cartilage defects in the rabbit: The effects of joint distraction and autologous bonemarrowderived mesenchymal cell transplantation. J. Bone Joint Surg. Br. 87, 721-729 (20056p
107. van Valburg, A. A.et al. Joint distraction in treatment of osteoarthritis (II): Effects on cartilage in a canine model. Osteoarthritis Cartilage 8, 1-8 (20006p
108. Karadam, B., Karatosun, V., Murat, N., Ozkal, S. & Gunal, I. No beneficial effects of joint distraction on early microscopical changes in osteoarthrotic knees. A study in rabbits. Acta Orthop. 76, 95-98 (20056p
109. Kroeber, M.et al. Effects of controlled dynamic disc distraction on degenerated intervertebral discs: An in vivo study on the rabbit lumbar spine model. Spine (Phila Pa 1976) 30, 181-187 (20056p
110. McAlindon, T. E., Driban, J. B. & Lo, G. H. Osteoarthritis year 2011 in review: clinical. Osteoarthritis Cartilage 20, 197-200 (20126p
111. Parker, D. A.,Beatty, K. T., Giuffre, B., Scholes, C. J. & Coolican, M. R. Articular cartilage changes in patients with osteoarthritis after osteotomy. Am. J. Sports Med. 39, 1039-1045 (20116p
112. Burr, D. B. & Gallant, M. A. Bone remodelling in osteoarthritis. Nat. Rev. Rheumatol. 8, 665-673 (20126p
113. Jones, E. A.et al. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: Detection and functional evaluation at the single-cell level. Arthritis Rheum. 58, 1731-1740 (20086p
114. Jones, E. A.et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 46, 3349-3360 (20026p
115. Koelling, S.et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 4, 324-335 (20096p
116. Vinardell, T., Buckley, C. T., Thorpe, S. D. & Kelly, D. J. Composition-function relations of cartilaginous tissues engineered from chondrocytes and mesenchymal stem cells isolated from bone marrow and infrapatellar fat pad. J. Tissue Eng. Regen. Med. 5, 673-683 (20116p
117. Richter, W. Mesenchymal stem cells and cartilage in situ regeneration. J. Intern. Med. 266, 390-405 (20096p
118. Grad, S., Eglin, D., Alini, M. & Stoddart, M. J. Physical stimulation of chondrogenic cells in vitro: A review. Clin. Orthop. Relat Res. 469, 2764-2772 (20116p
119. Nohmi, S.et al. Post injury changes in the properties of mesenchymal stem cells derived from human anterior cruciate ligaments. Int. Orthop. 36, 1515-1522 (20126p
120. Mobasheri, A., Csaki, C., Clutterbuck, A. L., Rahmanzadeh, M. & Shakibaei, M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: Applications in cartilage repair and osteoarthritis therapy. Histol. Histopathol. 24, 347-366 (20096p
121. Spector, T. D.et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: Results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res. Ther. 7, R625-R633 (20056p
122. Brandt, K. D., Mazzuca, S. A., Katz, B. P.et al. Effects of doxycycline on progression of osteoarthritis: Results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum. 52, 2015-2025 (20056p
123. Pavelká, K.et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study. Arch. Intern. Med. 162, 2113-2123 (20026p
124. Kahan, A., Uebelhart, D., De Vathaire, F., Delmas, P. D. & Reginster, J. Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 60, 524-533 (20096p
125. Sawitzke, A. D.et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum. 58, 3183-3191 (20086p
126. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT00911469 (20116p
127. Krzeski, P.et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: A randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res. Ther. 9, R109 (20076p
128. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/how/NCT00427687 (20076p